A. Haun
Veristat, LLC (United States) · 4 works · 17 citations · h-index 3
Top works
- 1625P Multicenter, randomized, parallel group, phase II study to establish the efficacy and safety of CBP501, cisplatin, and nivolumab for ≥ third-line treatment of patients with exocrine pancreatic cancer and WBC <10,000/mm3
- Influence of human lipoproteins on the progesterone synthesis of human term placenta in organ culture.
- A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma
- [Khellicor in heart disease therapy].